SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding Issuance of Letter Of Confirmation.12-07-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding Issuance of Letter Of Confirmation.SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Regulatory Order
Intimation regarding Statutory order passed by Custom Authority.SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Investor Presentation
SPIL-Investor PresentationSUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation regarding certificate under regulation 74(5) of SEBI (DP) Regulation, 2018SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Intimation regarding Newspaper Publication for Notice of 32nd Annual General Meeting.SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Reporting (BRSR) for the year ended March 31, 2024.Open to inorganic opportunities in specialty drugs, says Sun Pharma
Sun Pharma has net cash position of $2.4 bn at end of FY24; 6 new specialty products in R&D pipelineSUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Notice Of 32Nd Annual General Meeting Of Sun Pharmaceutical Industries To Be Held On Monday, August 5, 2024
Notice of 32nd Annual General Meeting of the Company to be held on Monday, August 5, 2024SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Reg. 34 (1) Annual Report.
Pursuant to Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the Annual Report for the financial year 2023-24 including the Notice of Thirty-second Annual General Meeting ('32nd AGM'), scheduled to be held on Monday, August 5, 2024 at 03:00 p.m. IST through Video Conferencing. The cut-off date for the purpose of determining the members eligible to vote on the resolutions set out in the Notice of 32nd AGM, is Monday, July 29, 2024. The remote e-voting period begins on Thursday, August 1, 2024 at 09:00 a.m. IST and ends on Sunday, August 4, 2024 at 05:00 p.m. IST.SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Validation of Nidlegy Marketing Authorization Application submission by EMA.